Epithelioma Treatment Market to reach USD 13.1 billion by 2035, driven by rising skin cancer cases and growing adoption of ...

First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...

Loqtorzi (toripalimab) showed significant improvement in progression-free survival for acral melanoma compared to standard chemotherapy in a phase 3 trial. Acral melanoma, a rare and aggressive ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

A study that was published in recent weeks has given the world a sobering view of the number of cancer diagnoses that are ...

On November 11, 2025, CheckMySpot(R) , the Direct Access Platform(TM) for early skin cancer detection, was honored during the 2025 National Alliance of Healthcare Purchaser Coalitions Annual Forum ...

A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO ...

When doctors showed Ross Leeder a scan revealing a mass in his brain after persistent headaches, vomiting and dizziness, he ...

Concerns are growing about complications caused by tattoos that range from mild skin irritations to more severe allergic ...

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for dermatology, ...

Recent findings reveal Cornell prime dots can activate the immune system against melanoma, improving cancer immunotherapy ...

CT scan of chest, abdomen, and pelvis shows high-disease burden, including multiple mediastinal and hilar nodes, deposits in ...